The low number of red blood cells is an important risk factor for all-cause mortality in the general population

Tohoku Journal of Experimental Medicine

Volumn 227, Issue 2, 2012, Pages 149-159

  Kim, Yong Chul ^a   Koo, Ho Suk ^b   Ahn, Shin young ^c   Oh, Se Won ^d   Kim, Sejoong ^c   Na, Ki Young ^c,e   Chae, Dong Wan ^c,e   Kim, Suhnggwon ^a,e   Chin, Ho Jun ^c,e  

^a Seoul National University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c Seoul National University Bundang Hospital   (South Korea)

^d Eulji General Hospital   (South Korea)

^e Seoul National University College of Medicine   (South Korea)

Author keywords

Glomerular filtration rate; Hemoglobin; Metabolic syndrome; Mortality; Red blood cell

Indexed keywords

ALBUMIN; CHOLESTEROL; HEMOGLOBIN; TRIACYLGLYCEROL; URIC ACID;

ADULT; AGE DISTRIBUTION; ALBUMIN BLOOD LEVEL; ANALYSIS OF COVARIANCE; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; ERYTHROCYTE COUNT; FEMALE; GENDER BIAS; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HEMATURIA; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERTENSION; MALE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; MORTALITY; OUTCOME ASSESSMENT; PROTEIN BLOOD LEVEL; PROTEINURIA; RISK FACTOR; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL;

ADULT; CAUSE OF DEATH; ERYTHROCYTE COUNT; ERYTHROCYTES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBINS; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODELS; REPUBLIC OF KOREA; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 84863853457     PISSN: 00408727     EISSN: 13493329     Source Type: Journal    
DOI: 10.1620/tjem.227.149     Document Type: Article

References (31)

1. Bitto, A., De Caridi, G., Polito, F., Calò, M., Irrera, N., Altavilla, D., Spinelli, F. & Squadrito, F. (2010) Evidence for markers of hypoxia and apoptosis in explanted human carotid atherosclerotic plaques. J. Vasc. Surg., 52, 1015-1021.
2. Del Fabbro, P., Luthi, J.C., Carrera, E., Michel, P., Burnier, M. & Burnand, B. (2010) Anemia and chronic kidney disease are potential risk factors for mortality in stroke patients: a historic cohort study. BMC Nephrol., 11, 27.
3. Deng, A., Tang, T., Singh, P., Wang, C., Satriano, J., Thomson, S.C. & Blantz, R.C. (2009) Regulation of oxygen utilization by angiotensin II in chronic kidney disease. Kidney Int., 75, 197-204.
4. Duke, M. & Abelmann, W.H. (1969) The hemodynamic response to chronic anemia. Circulation, 39, 503-515.
5. Dunn, A., Lo, V. & Donnelly, S. (2007) The role of the kidney in blood volume regulation: the kidney as a regulator of the hematocrit. Am. J. Med. Sci., 334, 65-71.
6. Fazlibegović, E., Hadziomerović, M., Corić, S., Babić, E. & Fazlibegović, F. (2006) Erythropoietin in cardiorenal anemia syndrome. Bosn. J. Basic Med. Sci., 6, 36-41.
7. Fisher, J.W. (2003) Erythropoietin: physiology and pharmacology update. Exp. Biol. Med. (Maywood), 228, 1-14.
8. Ganz, T. (2007) Molecular control of iron transport. J. Am. Soc. Nephrol., 18, 394-400.
9. Go, A.S., Yang, J., Ackerson, L.M., Lepper, K., Robbins, S., Massie, B.M. & Shlipak, M.G. (2006) Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation, 113, 2713-2723.
10. Grundy, S.M., Cleeman, J.I., Daniels, S.R., Donato, K.A., Eckel, R.H., Franklin, B.A., Gordon, D.J., Krauss, R.M., Savage, P.J., Smith, S.C. Jr., Spertus, J.A. & Costa, F.; American Heart Association; National Heart, Lung, and Blood Institute. (2005) Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, 112, 2735-2752.
11. Hawkey, C.M., Bennett, P.M., Gascoyne, S.C., Hart, M.G. & Kirk-wood, J.K. (1991) Erythrocyte size, number and haemoglobin content in vertebrates. Br. J. Haematol., 77, 392-397.
12. Hultén, L.M. & Levin, M. (2009) The role of hypoxia in atherosclerosis. Curr. Opin. Lipidol., 20, 409-414.
13. Koury, M.J. & Ponka, P. (2004) New insights into erythropoiesis: the roles of folate, vitamin B12, and iron. Annu. Rev. Nutr., 24, 105-131.
14. Lerman, L.O., Textor, S.C. & Grande, J.P. (2009) Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond. Prog. Cardiovasc. Dis., 52, 196-203.
15. Levey, A.S., Coresh, J., Greene, T., Stevens, L.A., Zhang, Y.L., Hendriksen, S., Kusek, J.W. & Van Lente, F.; Chronic Kidney Disease Epidemiology Collaboration. (2006) Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann. Intern. Med., 145, 247-254.
16. Levin, A., Djurdjev, O., Duncan, J., Rosenbaum, D. & Werb, R. (2006) Haemoglobin at time of referral prior to dialysis predicts survival: an association of haemoglobin with long-term outcomes. Nephrol. Dial. Transplant., 21, 370-377.
17. Lin, H.Y. (2009) Erythropoiesis: The roles of Erythropoietin and Iron. In Textbook of Nephro-Endocrinology, 1st ed., edited by A.K. Singh & G.H. Williams. Elsevier, New York, NY, pp. 19-26.
18. Mann, J.F. (1999) What are the short-term and long-term consequences of anaemia in CRF patients? Nephrol. Dial. Transplant., 14(Suppl 2), 29-36.
19. Mercadal, L., Metzger, M., Casadevall, N., Haymann, J.P., Karras, A., Boffa, J.J., Flamant, M., Vrtovsnik, F., Stengel, B. & Froissart, M.; NephroTest Study Group. (2012) Timing and Determinants of Erythropoietin Defciency in Chronic Kidney Disease. Clin. J. Am. Soc. Nephrol., 7, 35-42.
20. Moranne, O., Froissart, M., Rossert, J., Gauci, C., Boffa, J.J., Haymann, J.P., M'rad, M.B., Jacquot, C., Houillier, P., Stengel, B. & Fouqueray, B.; NephroTest Study Group. (2009) Timing of onset of CKD-related metabolic complications. J. Am. Soc. Nephrol., 20, 164-171.
21. Nakul-Aquaronne, D., Sudaka-Sammarcelli, I., Ferrero-Vacher, C., Starck, B. & Bayle, J. (2003) Evaluation of the Sysmex Xe-2100 hematology analyzer in hospital use. J. Clin. Lab. Anal., 17, 113-123.
22. National Kidney Foundation. (2000) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Part 5. Evaluation of laboratory measurements for clinical assessment of kidney disease. Am. J. Kidney Dis., 39, S111-S169.
23. Oh, S.W., Baek, S.H., Kim, Y.C., Goo, H.S., Heo, N.J., Na, K.Y., Chae, D.W., Kim, S. & Chin, H.J. (2012) Higher hemoglobin level is associated with subtle declines in renal function and presence of cardiorenal risk factors in early CKD stages. Nephrol. Dial. Transplant., 27, 267-275.
24. Papayannopoulou, T. & Finch, C.A. (1972) On the in vivo action of erythropoietin: a quantitative analysis. J. Clin. Invest., 51, 1179-1185.
25. Peti-Peterdi, J. & Harris, R.C. (2010) Macula densa sensing and signaling mechanisms of renin release. J. Am. Soc. Nephrol., 21, 1093-1096.
26. Pollock, J.S. & Carmines, P.K. (2008) Diabetic nephropathy: nitric oxide and renal medullary hypoxia. Am. J. Physiol. Renal Physiol., 294, F28-F29.
27. Ponka, P. (1997) Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells. Blood, 89, 1-25.
28. Radtke, H.W., Claussner, A., Erbes, P.M., Scheuermann, E.H., Schoeppe, W. & Koch, K.M. (1979) Serum erythropoietin concentration in chronic renal failure: relationship to degree of anemia and excretory renal function. Blood, 54, 877-884.
29. Remuzzi, G. & Minetti, L. (2000) Hematologic consequences of renal failure. In Brenner and Rector's The Kidney, 6th ed., edited by B.M. Brenner. WB Saunders, Philadelphia, PA, pp. 2079-2102.
30. Tibblin, E., Bengtsson, C., Hallberg, L. & Lennartsson, J. (1979) Haemoglobin concentration and peripheral blood cell counts in women. The population study of women in Göteborg 1968-1969. Scand. J. Haematol., 22, 5-16.
31. Uehata, T., Tomosugi, N., Shoji, T., Sakaguchi, Y., Suzuki, A., Kaneko, T., Okada, N., Yamamoto, R., Nagasawa, Y., Kato, K., Isaka, Y., Rakugi, H. & Tsubakihara, Y. (2012) Serum hepcidin-25 levels and anemia in non-dialysis chronic kidney disease patients: a cross-sectional study. Nephrol. Dial. Transplant., 27, 1076-1083.